---
$id: https://graph.org.ai/products/commodity/51161550
$type: Product
source: UNSPSC
code: "51161550"
title: "Ontazolast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ontazolast

**UNSPSC Code**: 51161550
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C21H25N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8P8TW6B25I, chemically known as 2-benzoxazolamine, n-(2-cyclohexyl-1-(2-pyridinyl)ethyl)-5-methyl-, (s)- but generally known as ontazolast, which bears US NIH Compound Identifier 71458. European Medicines Agency schedules Ontazolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09446MIG. The term ONTAZOLAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). ONTAZOLAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ontazolast under HS 29349990 and SITC 51579. As of Q4 2014, ONTAZOLAST remains the US FDA Preferred Term for this commodity. Ontazolast bears US NLM identifiers UMLS ID C0663012 and NCI Concept Code C79123. SMILES: O1C(NC(CC2CCCCC2)C2NCCCC2)NC2C1CCC(C2)C.

